Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.40 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.31 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 2/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12229258 | 0.94 | ALOX5 (0.36) | ALOX5GGPS1HDAC8PRKDCAVPR1A | |
| SCHEMBL12229293 | 0.93 | ALOX5 (0.35) | ALOX5GGPS1 | |
| SCHEMBL13860947 | 0.91 | ALOX5 (0.47) | ALOX5GGPS1NPC1RAB9AMEN1 | |
| SCHEMBL12229294 | 0.91 | ALOX5 (0.38) | ALOX5GGPS1MAPTPRKDCALDH1A1 | |
| SCHEMBL12229297 | 0.91 | ALOX5 (0.36) | ALOX5GGPS1 | |
| SCHEMBL9890829 | 0.89 | ALOX5 (0.46) | ALOX5GGPS1NPC1RAB9AMAPT | |
| SCHEMBL2250911 | 0.89 | ALOX5 (0.46) | ALOX5GGPS1NPC1RAB9AMAPT | |
| SCHEMBL29306842 | 0.86 | ALOX5 (0.44) | ALOX5GGPS1NPC1RAB9AMAPT | |
| SCHEMBL12377417 | 0.83 | ALOX5 (0.41) | ALOX5GGPS1NPC1RAB9AMAPT | |
| SCHEMBL9890834 | 0.83 | ALOX5 (0.43) | ALOX5GGPS1NPC1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110248217-A1 | ELECTROLUMINESCENT DEVICE | UDC IRELAND LIMITED (IE) | 2011-10-13 | — | — | US | disclosed |
| US-7989644-B2 | Electroluminescent device | BASF SE (DE) | 2011-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110248217-A1 | ELECTROLUMINESCENT DEVICE | DDT, CD99, EED | ALOX5 741/4885GGPS1 2096/4885NPC1 4590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.